(Q34637026)

3 August 2017

1 reference

title

Menorrhagia from a haematologist's point of view. Part I: initial evaluation (English)

1 reference

3 August 2017

1 reference

Kouides PA

1

1 reference

3 August 2017

publication date

1 May 2002

1 reference

3 August 2017

1 reference

3 August 2017

volume

8

1 reference

3 August 2017

issue

3

1 reference

3 August 2017

page(s)

330-338

1 reference

Fortnightly review. Medical management of menorrhagia

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00634.X

Severe factor VIII and factor IX deficiency in females

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00634.X

Assessment of menstrual blood loss and gynaecological problems in patients with inherited bleeding disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00634.X

Quality of life during menstruation in patients with inherited bleeding disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00634.X

von Willebrand disease and bleeding in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00634.X

Gynaecological and obstetrical morbidity in women with type I von Willebrand disease: results of a patient survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00634.X

Self-treatment with desmopressin intranasal spray in patients with bleeding disorders: effect on bleeding symptoms and socioeconomic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00634.X

Nasal spray desmopressin (DDAVP) for mild hemophilia A and von Willebrand disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00634.X

High-dose DDAVP intranasal spray (Stimate) for the prevention and treatment of bleeding in patients with mild haemophilia A, mild or moderate type 1 von Willebrand disease and symptomatic carriers of haemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00634.X

von Willebrand disease and other inherited bleeding disorders in women with diagnosed menorrhagia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00634.X

Females with von Willebrand disease: 72 years as the silent majority

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00634.X

Obstetric and gynaecological aspects of von Willebrand disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00634.X

A simple visual assessment technique to discriminate between menorrhagia and normal menstrual blood loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00634.X

Frequency of inherited bleeding disorders in women with menorrhagia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00634.X

Acquired von Willebrand's disease and hypothyroidism: report of a case presenting with menorrhagia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00634.X

Acquired von Willebrand syndrome type 1 in hypothyroidism: reversal after treatment with thyroxine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00634.X

Adverse events during use of intranasal desmopressin acetate for haemophilia A and von Willebrand disease: a case report and review of 40 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00634.X

Platelet Function Defects: A Clinical Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00634.X

Minocycline-induced pigmentation. Incidence, prevention and management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00634.X

Type 1 von Willebrand disease - a clinical retrospective study of the diagnosis, the influence of the ABO blood group and the role of the bleeding history

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00634.X

Coagulation and fibrinolysis during the normal menstrual cycle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00634.X

Management of von Willebrand disease: a survey on current clinical practice from the haemophilia centres of North America

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00634.X

Utility of the PFA-100 for assessing bleeding disorders and monitoring therapy: a review of analytical variables, benefits and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00634.X

Menstruation: Extravascular Fibrinolytic Activity and Reduced Fibrinolytic Capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00634.X

Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2002.00634.X

10.1046/J.1365-2516.2002.00634.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference